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Abstract
Background: In vitro exposure of liver cells to high concentrations of free fatty acids (FFA) results in fat overload
which promotes inflammatory and fibrogenic response similar to those observed in patients with Non-Alcoholic
Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH). Since the mechanisms of this event have
not been fully characterized, we aimed to analyze the fibrogenic stimuli in a new in vitro model of NASH.
Methods: HuH7 cells were cultured for 24 h in an enriched medium containing bovine serum albumin and
increasing concentrations of palmitic and oleic acid at a molar ratio of 1:2 (palmitic and oleic acid, respectively).
Cytotoxic effect, apoptosis, oxidative stress, and production of inflammatory and fibrogenic cytokines were
measured.
Results: FFA induces a significant increment in the intracellular content of lipid droplets. The gene expression of
interleukin-6, interleukin-8 and tumor necrosis factor alpha was significantly increased. The protein level of
interleukin-8 was also increased. Intracellular lipid accumulation was associated to a significant up-regulation in the
gene expression of transforming growth factor beta 1, alpha 2 macroglobulin, vascular endothelial growth factor A,
connective tissue growth factor, insulin-like growth factor 2, thrombospondin 1. Flow cytometry analysis
demonstrated a significant increment of early apoptosis and production of reactive oxygen species.
Conclusions: The exposure of hepatocytes to fatty acids elicits inflammation, increase of oxidative stress, apoptosis
and production of fibrogenic cytokines. These data support a primary role of FFA in the pathogenesis of NAFLD
and NASH.
Background
Non-alcoholic fatty liver disease (NAFLD) is a common
disease associated to obesity and increased visceral fat.
This condition has the potential to develop hepatic
fibrosis and end-stage liver disease, and is associated
with several non-hepatic related complications [1]. Liver
fibrosis is a complex event that could be conceptually
divided in three phases: initiation, perpetuation and
resolution: each of these phases has specific pathways.
Classically, the hepatic stellate cell and immune cells are
the main players in the fibrotic process [2] but the role
of the hepatocyte is also important, mainly in the initia-
tion phase due to production of several fibrogenic sti-
muli, particularly reactive oxygen species (ROS) [3] and
apoptosis [4]. Recently it has been described the
production by the hepatocyte of several cytokines
involved in the fibrogenesis, and in vitro studies with
liver cells exposed to toxic amounts of free fatty acids
(FFA) demonstrated that this condition could promote
and inflammatory and fibrogenic response [5].
The hepatocyte-mediated fibrogenic response is regu-
lated by cytokines involved in proliferation (as the trans-
forming growth factor beta 1 [TGFb1], alpha 2
macroglobulin [Α2M], vascular endothelial growth factor
A [VEGFA], connective tissue growth factor [CTGF], and
insulin-like growth factor 2 [IGF2]) and in the regulation
of apoptosis (as the nerve growth factor [NGF], and
thrombospondin 1 [THBS1]) [2]. In spite of its impor-
tance, the fibrogenic response has not been fully explored
in NAFLD, and it is also unknown if non toxic amounts
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production of fibrogenic stimulus in a new in vitro
model of non-alcoholic steatohepatitis (NASH).
Methods
Chemicals
Cell culture medium Dulbecco’s modified Eagle’s high glu-
cose medium (DMEM) (ECB7501L), L- Glutamine
(ECB3000D), Penicillin/Streptomycin (ECB3001D), were
obtained from Euro-clone (Milan, Italy). Bicinconinc acid
solution-kit (B9643); bovine albumin Cohn V fraction
(A4503); dimethyl sulphoxide (DMSO) (D2438); fetal
bovine serum (F7524); Hoechst 33258 (B1155); hydrogen
peroxide (H1009); 3-(4,5 dimethylthiazol-yl-)-2,5-diphenil-
tetrazoliumbromide (MTT) (M2128); N-acetyl-L-cysteine
(NAC) (A9165); Nile Red (N3013); oleic acid (C18:1)
(O1008); palmitic acid (C16:0) (P0500); paraformaldehyde
(P6148), phosphate-buffered saline (PBS) (D5652); propi-
dium iodide (PI)(P4170) and Tri-Reagent (T9424) were
from Sigma Chemical (St.Louis, MO, USA). iScript
™
cDNA Synthesis kit (170-8890) and iQ SYBR Green
Supermix (170-8860) were purchased from Bio-Rad
Laboratories (Hercules, CA, USA). 2’,7’-dichlorodihydro-
fluorescein diacetate (H2DCFDA) (D399) was obtained
from Molecular Probes (Milan, Italy). Human annexin
V-FITC Kit (BMS306FICE); Instant ELISA kit interleukin
(IL)-6, IL-8 and tumor necrosis factor (TNF)-alpha
(BMS213INSTCE; BMS204/3INSTCE; BMS223INSTCE
respectively) were purchased to Bender MedSystems
GmbH (Vienna, Austria)
Cell culture and FFA treatment
Hepatoma derived cell line HuH7 (JHSRRB, Cat
#JCRB0403) were obtained from the Health Science
Research Resources Bank (Osaka, Japan). Cells were
grown in DMEM high glucose medium supplemented
with 10% v/v fetal bovine serum, 2 mM L-Glutamine,
10,000 U/mL penicillin and 10 mg/mL streptomycine at
37°C under 5% CO2, in a 95% humidified atmosphere. For
the treatment, palmitic and oleic acid 0.1 M stock solu-
tions were prepare by dissolving FFA in DMSO. The cells
were exposed for 24 h to increasing concentrations of a
fresh mixture of exogenous FFA (100; 200; 400; 600 and
1200 μM) in molar ratio 1:2 palmitic:oleic respectively.
Since albumin concentration is an important factor in
determining the concentration of available FFA, the FFA
were complexed with bovine serum albumin at a 4:1
molar ratio taking into consideration the albumin concen-
tration already present in the medium due to the FBS sup-
plementation. The experimental doses were determined in
advance by performing dose curves and by assessing cell
viability which was always higher than 85% as compared
to control cells (100% viability) treated with the equivalent
concentration v/v of the vehicle (DMSO).
MTT assay
Cell viability was assessed using the MTT colorimetric
assay. When taken up by living cells, MTT is converted
from a yellow to a water insoluble blue-colored precipitate
by cellular dehydrogenases [6]. Briefly, 4 × 10
4 cells/cm
2
were plated in 24 well dish and allowed to adhere over-
night. The following day the cells were treated as
described above. After 24 h of treatment, the medium was
removed and the treatment was followed by addition of
0.5 mg/mL of MTT and incubation at 37°C for 1 h. The
medium was then removed, the cells were lysed and the
resulting blue formazan crystals were solved in DMSO.
T h ea b s o r b a n c eo fe a c hw e l lw a sr e a do nam i c r o p l a t e
reader (Beckman Coulter LD 400 C Luminescence detec-
tor) at 570 nm. The absorbance of the untreated controls
was taken as 100% survival. Data are expressed as mean ±
SD of three independent experiments.
Fluorimetric determination of intracellular fat content -
Nile red staining
Intracellular fat content was determined fluorimetrically
based on Nile Red staining, a vital lipophilic dye used to
label fat accumulation in the cytosol [7,8]. After 24 h of
FFA exposure, adherent monolayer cells were washed
twice with PBS and detached by tripsinization. After a
5 min centrifugation at 1500 rpm, the cell pellet was resus-
pended in 3 mL of PBS and incubated with 0.75 μg/mL
Nile red dye for 15 min at room temperature.
Nile red intracellular fluorescence was determined by
flow cytofluorometry using a Becton Dickinson FACS-
Calibur System on the FL2 emission channel through a
585 ± 21 nm band pass filter, following excitation with
an argon ion laser source at 488 nm [9]. Data were col-
lected in 10,000 cells and analyzed using Cellquest soft-
ware from BD Biosciences (San Jose, CA, USA).
Intracellular lipid droplets analysis by fluorescence
microscopy
HuH7 cells were seeded in a coverslip and exposed to FFA
for 24 h as previously described. Cells were then washed
with PBS twice, and fixed with 3% paraformaldehide for
15 min. Intracellular neutral lipids were stained with Nile
Red (3.3 μg/mL) for 15 min. Cell nuclei were stained with
Hoescht 33258 dye for 15 min. All the staining procedure
was carried out at room temperature by protecting the
samples from the direct light. Images were acquired with
an inverted fluorescence microscope (Leica DM2000,
Wetzlar Germany)
Extraction of RNA and cDNA synthesis
After the treatment, the medium was removed, cells
were washed twice with PBS and after centrifugation,
total RNA isolated using Tri-Reagent kit according to
manufacturer’s instructions. Briefly, cells were lysed with
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was precipitated by isopropyl alcohol. After washing
with 75% ethanol, the RNA pellet was dissolved in
nuclease-free water and stored at -80°C until further
analysis. RNA was quantified spectrophotometrically at
2 6 0n mi naB e c k m a nC o u l t e rD U
®730 spectrophot-
ometer (Fullertone, CA, USA). The RNA purity was
evaluated by measuring the ratio A260/A280, consider-
ing RNA with appropriate purity those showing values
between 1.8 and 2.0; its integrity was evaluated by gel
electrophoresis. The integrity of RNA was assessed on
standard 1% agarose/formaldehyde gel. Isolated RNA
was resuspended in RNAse free water and stored at -80°
C until analysis. Total RNA (1 μg) was reverse tran-
scribed using iScript
™ cDNA Synthesis kit BioRad
according to manufacturer’s instructions. Retrotranscrip-
tion was performed in a Thermal Cycler (Gene Amp
PCR System 2400, Perkin Elmer, Boston, MA, USA) in
agreement with the reaction protocol proposed by the
manufacturer’s: 5 min at 25°C (annealing), 45 min at 42°
C (cDNA synthesis), and 5 min at 85°C (enzyme
denaturation).
Real time quantitative PCR
Real Time quantitative PCR was performed in i-Cycler
IQ; 18S and b-actin were used as housekeeping genes.
All primer pairs were synthesized by Sigma Genosys Ltd.
(London Road, UK) and were designed using the software
Beacon Designer 7.51 (PREMIER Biosoft International,
Palo Alto, CA, USA). Primer sequences and references
are specified in Table 1. PCR amplification was carried
out in 25 μL reaction volume containing 25 ng of cDNA,
1x iQ SYBR Green Supermix [100 mM KCl; 40 mM Tris-
HCl, pH 8.4; 0.4 mM each dNTP; 50 U/mL iTaq DNA
polymerase; 6 mM MgCl2; SYBR Green I; 20 nM fluores-
cein; and stabilizers] and 250 nM gene specific sense and
anti-sense primers and 100 nM primers for 18S. Standard
curves using a “calibrator” cDNA (chosen among the
cDNA samples) were prepared for each target and
reference gene. In order to verify the specificity of the
amplification, a melt-curve analysis was performed,
immediately after the amplification protocol. Non-speci-
fic products of PCR were not found in any case. The rela-
tive quantification was made using the Pfaffl modification
of the ΔΔCt equation, taking into account the efficiencies
of individual genes. The results were normalized to 18S
and b-actin, the initial amount of the template of each
sample was determined as relative expression versus one
of the samples chosen as reference (in this case the con-
trol sample) which is considered the 1x sample. Results
reported are the mean ± SD expression of at least 3 dif-
ferent determinations for each gene.
IL-6, IL-8 and TNF-alpha release
The cytokine released in the culture media was deter-
mined by Instant ELISA (Bender MedSystems GmbH;
Vienna Austria) according to manufacturer’s instructions.
Cells were cultured and treated as previously described.
The culture media was collected after 24 h, possible con-
tamination of cellular fractions was eliminated by centrifu-
gation and the test performed in cell-free supernatant.
According to the manufacturer the lowest detection limits
were: 0.92 pg/mL for IL-6, 1.3 pg/mL for IL-8 and 1.65
pg/mL for TNF-alpha.
Intracellular ROS generation by H2DCFDA
Intracellular ROS generation was measured by the use of
the cell permeable fluorogenic substrate H2DCFDA. This
non fluorescent probe is easily taken up by cells and, after
intracellular cleavage of the acetyl groups, is trapped and
may be oxidized to the fluorescent compound 2’,7’-
dichlorofluorescin (DCF; the monitored fluorophore) by
intracellular ROS [10]. Cells were exposed to FFA for 24 h
and after the treatment, adherent cells were washed with
PBS, and loaded with 10 μMH 2DCFDA for 15 min at
37°C. The fluorescence was measured by using a Spectro-
fluorometer Jasco FP-770 (Excitation wavelength 505 nm
and Emission 525 nm). Fluorescence was normalized by
Table 1 Set of primers used in Real-time quantitative PCR
Gene name Accession number Forward Reverse
Interleukin L6 NM_000600 ACAGATTTGAGAGTAGTGAGGAAC GGCTGGCATTTGTGGTTGG
Interleukin 8 NM_000584 GACATACTCCAAACCTTTCCAC CTTCTCCACAACCCTCTGC
Tumor necrosis factor alpha NM_000594 GTGAGGAGGACGAACATC GAGCCAGAAGAGGTTGAG
Transforming growth factor beta NM_000660 GCAACAATTCCTGGCGATACC CTCCACGGCTCAACCACTG
Alpha 2 macroglobulin NM_000014 AACCAGGACAAGAGGAAGGAAG AGATAAGCGAGGAGCACATAGG
Vascular endothelial growth factor A NM_003376 TCGCTTACTCTCACCTGCTTC TTCCAACAATGTGTCTCTTCTCTTC
Nerve growth factor NM_002506 AGGAGCAAGCGGTCATCATC TCTGTGGCGGTGGTCTTATC
Connective tissue growth factor NM_001901 CGAGGAGTGGGTGTGTGAC CAGGCAGTTGGCTCTAATCATAG
Thrombospondin 1 NM_003246 ACCAACCGCATTCCAGAGTC CCGCACAGCATCCACCAG
Insulin-like growth factor 2 NM_000612 CGCTGCTACCGCCATCTC GTCCCTCTGACTGCTCTGTG
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assay [11] and expressed as AU/μgo fp r o t e i n .T h ei n t r a -
cellular ROS production was also assessed by flow cyto-
metric analysis by using Becton Dickinson FACSCalibur
System. Briefly, attached cells were harvested by tripsiniza-
tion, washed in PBS by centrifugation, and incubated with
5 μMH 2DCFDA for 30 min at 37°C in PBS, to exclude
hydrogen peroxide generation in phenol red containing
media. The cells were washed in PBS and the pellet was
suspended in 500 μL of PBS. PI staining was performed to
assess non viable cells. Cells within a negative control gate
for PI fluorescence were back-gated (FL2) and the fluores-
cence histogram for H2DCFDA (FL1) was applied for the
living cells [12]. Considering the potential anti-oxidant
effect of albumin [13], the albumin concentration was kept
the same in the controls and in the treated samples. Cells
exposed to 400 μM hydrogen peroxide were considered as
positive control. In order establish if the ROS production
induced by FFA could be reversed by an antioxidant
agent, cells were co-treated with FFA and 300 μM n-acet-
ylcysteine (NAC). The optimal NAC concentration was
established by performing dose curve analysis by MTT, at
the used concentration cell viability was unaltered (data
not shown). Data were collected for 10,000 cells and ana-
lyzed using CellQuest software from BD Biosciences (San
Jose, CA).
Assessment of apoptosis
During apoptosis, phosphatidyl serine is exposed from the
inner to the outer portion of the membrane and becomes
available to bind to the Annexin-V/FITC conjugate.
Accordingly, only cells prone to apoptosis will stain positive
for Annexin-V/FITC [14]. The cells were harvested by gen-
tle tripsinization which was inactivated by adding medium
with 10% FBS. Cells were washed, the pellet suspended in
the incubation buffer (10 mM Hepes/NAOH, pH 7.40, 140
mM NaCl, 5 mM CaCl2) adjusting cell density to 5 × 10
6
cell/mL, and 1 × 10
6 cells were incubated with 5 μL
Annexin V-FITC and 5 μL PI for 10 min at room tempera-
ture. The cells were diluted with the incubation buffer to a
final volume of 600 μL and analyzed by flow cytometer
using 488 nm excitation and 515 nm band-pass filter for
fluorescein detection (FL1) and a filter > 600 nm for PI
detection (FL2). Data were collected for 10,000 cells and
analyzed using CellQuest software from BD Biosciences
(San Jose, CA).
Statistical analysis
Unless otherwise indicated all the data are expressed as
mean ± standard deviation of three independent experi-
ments (biological replicates). Differences between groups
were compared by using Student’s t test. The level of sig-
nificance was set at a P-value of 0.05.
Results
Toxicity of the model
The addition of increasing concentrations of FFA (pal-
mitic/oleic 1:2 molar ratio) did not affect the cell viabi-
lity measured by MTT Test (data not shown). To assess
the effect of the vehicle in which FFA were solubilized,
cells were also treated with the equivalent concentration
of DMSO of each FFA concentration. In both cases via-
bility was not significantly reduced (10-15%) after 24-h
incubation even at the DMSO concentration used with
the highest FFA concentrations used (1200 μm).
Intracellular fat overload
The content of intracellular lipid droplets was deter-
mined by Nile Red staining. Cell exposure to 600 and
1200 μM FFA for 24 h induced a dose-dependent fat
accumulation. Microscopic images (Figure 1A) showed
the presence of cytoplasmic lipid droplets. This pattern
was particularly evident after the exposure at 1200 μM
F F Aw h e r et h eq u a n t i t ya n ds i z eo ft h ed r o p l e t s
increased as compared with that seen with the lower
dose. This qualitative data was confirmed by flow cyto-
metry where the presence of cytoplasmatic lipids
induced a shift in the median of the fluorescence peak
(Figure 1B). After the treatment with FFA, a clear
increase of events was observed both in M1 and M2
regions, where M1 represents the percentage of events
above the maximum value and M2 the percentage of
events above the median value of fluorescence. The total
mean fluorescence shows a dose dependent accumula-
tion of FFA (Table 2).
Inflammatory cytokines mRNA expression
The role of inflammatory cytokines in the response of
liver cells to several injuries has been described [15].
F i g u r e2s h o w st h eg e n ee x p r e s s i o no fI L - 6 ,I L - 8a n d
TNF-alpha after 24 h of FFA-exposure. All the 3 cyto-
kines were significantly over-expressed as compared to
cells treated with the vehicle. However while IL-6
showed a 3-fold increase with no difference between the
two doses used, IL-8 showed a clear dose-dependency
w i t ha3 - f o l dd i f f e r e n c em o v i n gf r o m6 0 0μM to 1200
μM. Conversely, no increment was observed for TNF-
alpha at 600 μM while exposure to 1200 μM resulted in
a 5-fold up-regulation in the gene expression.
Cell release of IL-6, IL-8 and TNF-alpha in the culture
medium
To investigate if the up-regulation in the mRNA expres-
sion was associated to an increased cytokine cell pro-
duction, the cytokine release into the culture media was
also assessed. In line with the data obtained in the
mRNA expression (Figure 2), the production of IL-8
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μM (1484 ± 14 vs. 900 ± 246 pg/mL, p < 0.05) and
1200 μM (2613 ± 354 vs. 900 ± 246 pg/mL, p < 0.05) of
FFA (Figure 3). On the contrary and differently from
the gene expression, no significant changes were
observed for TNF-alpha at any of the experimental con-
centrations. In line with previous studies [16], IL-6 level
was lower than the sensitivity of the method.
Gene expression of fibrogenic cytokines
The involvement of hepatocytes on fibrogenesis has
been previously described, and the first phase of fibrosis
seems to be mediated by many cytokines [2,16]. To
analyze the effect of FFA in our in vitro model, a series
of cytokines reported as marker of fibrosis in NAFLD
[17] and in other liver diseases [18] were assessed. As
shown in Figure 4, the intracellular lipid accumulation
was associated with a significant up-regulation in
TGFb1, A2M, VEGFA, CTGF, THBS and IGF-2 mRNA.
Among these cytokines, the highest increment in gene
expression was observed for TGFb1( 1 . 9 9±0 . 2 3a n d
2.33 ± 0.19 folds of expression vs. control for 600 and
1200 μM, respectively). The same pattern of expression
was also observed for all the other cytokines with the
exception of a non significant increase for A2M and
IGF2 at the lower FFA concentration.
Figure 1 Dose dependent intracellular fat accumulation. Cell exposure to 600 and 1200 μM FFA for 24 h. Dose dependent intracellular fat
accumulation evidenced by Nile Red staining assessed by fluorescence microscopy (A) and flow cytometry measured in 1 × 10
4 cells (B), M1
represents the percentage of events above the maximum value of fluorescence and M2 represents the percentage of events above the median
value of fluorescence.
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Cells treated with 1200 μM FFA showed a 1.38 ± 0.12
(p < 0.05) folds of increase in ROS generation vs.
untreated control (Additional file 1: Figure S1 upper
panel). The ROS generation was similar to that observed
in positive control cells exposed to 400 μMh y d r o g e n
peroxide for 3 h (1.48 ± 0.22 folds of increase, p < 0.05).
When cells treated wither with FFA or hydrogen perox-
ide were concomitantly exposed to 300 μMo fN A C ,t h e
ROS level decreased to 1.22 ± 0.12 and 1.07 ± 0.16 (P =
NS) fold respectively, indicating that the addition of
NAC was able to reverse the alteration in redox state
induced by both FFA treatment and hydrogen peroxide.
The increment in ROS in FFA treated cells was also
confirmed by flow cytometry analysis (333 vs.375 AU
respectively) (Additional file 2: Figure S2 lower panel).
Assessment of apoptosis
HuH7 cells were stained with Annexin V and PI to
detect cells with disrupted membrane. According to the
cell staining, cells were categorized as: 1) live cells nega-
tive for both annexin V-FITC and PI; 2) early apoptotic
cells, positive for annexin V-FITC and negative for PI;
and 3) late apoptotic cells, positive both for annexin-V-
FITCH and PI; cells positive only for PI were considered
as necrotic. As shown in Figure 5A 1200 μM of FFA
induce an increase in the percentage of cells in early
apoptosis (6.2%), late apoptosis (2.1%) and a 4.23%
increase in the necrotic population (Figure 5B).
Discussion
Previous studies showed that the hepatocyte plays a key
role in the initiation of fibrosis, and that these events
are linked to inflammation, oxidative stress [19] and
apoptosis [2]. Studies carried out in vivo [20] and in
vitro models [4] reported the role of several cytokines
Figure 2 Inflammatory cytokines mRNA expression. Cells were
cultured and treated with 600 and 1200 μM FFA for 24 h. mRNA
expression of IL-6, IL-8 and TNF-alpha in HuH7 cells vs. control. * P
< 0.05 versus control (0 μM).
Figure 3 Inflammatory cytokines protein production.
Inflammatory cytokines present in the supernatant of HuH7 cells
after 24 h of the treatment was significantly increased only for IL-8
at both experimental doses, TNF-alpha levels were unchanged, and
the levels of IL-6 were lower than the assay sensitivity. * P < 0.05
versus control (0 μM).
Table 2 Intracellular fat accumulation assess by flow
cytometry by Nile Red staining.
Folds of relative fluorescence vs. control P-value
Control 1.00 ± 0.20
600 μM 2.00 ± 0.21 < 0.05
1200 μM 2.50 ± 0.04 < 0.05
The data represent the mean ± SD of three independent experiments.
Figure 4 Fibrogenic cytokines mRNA expression.F i b r o g e n i c
cytokines mRNA expression in HuH7 cells after 24 h exposure at
600 and 1200 μM FFA. * P < 0.05 versus control (0 μM).
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stellate cells [21]. More recently extensive evidence was
provided on the events associated with the hepatic lipo-
toxicity [22] with the hepatocyte as the main target of
the so called “lipoapoptosis” [23]. In the present work
we describe a novel in vitro model able to mimic most
of the processes observed in vivo during the initiation of
hepatic fibrosis. A well differentiate hepatic cell line
(HuH7) was exposed to different concentrations of a
mixture of saturated and non-saturated FFA similar to
those found in humans [24]. In addition to the concen-
tration of FFA, the albumin:FFA molar ratio was set to
1:4 [25], since this ratio is important to determine the
concentration of the free species of FFA. Moreover, the
addition to albumin increases the stability and solubility
of FFA in culture medium [26]. With this experimental
setup, we observed a dose-dependent intracellular fat
accumulation which was not associated to a significant
reduction in cell viability, at least for the time frame
investigated (24 h). These results point to the conclusion
that the hepatic cell line used is able to accumulate FFA
and the increased fat content is not associated to a sig-
nificant impairment of the cell integrity, in line with
clinical and in vivo experimental data [27]. Similar
results were also observed by using no tumoral immor-
talized human hepatocytes (IHH) [28], even though at a
Figure 5 Apoptosis induction secondary to fatty acids toxicity. FFA treatment increase apoptosis in hepatic cells (HuH7). There is a
reduction in the live cells, and in consequence an increase number of cells in early-, late-apoptosis and necrosis with the FFA treatment. The
results are presented as percentage compared to control and represent the mean ± SD, of at least three independent experiments (A).
Representative dotplot graph of control and 1200 μM FFA treated cells stained with Annexin V and PI (B).* P < 0.05 versus control (0 μM).
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accumulation and the inflammatory response was con-
sistently higher and the cell viability significantly
reduced (data not shown) [29]. One possible reason for
this discrepancy is that the increased FFA susceptibility
would be due to the immortalization process, which
may introduce alterations in the lipid metabolism.
The importance and novelty of our model is the possi-
bility to measure gene induction and protein expression
of the cytokines involved in the pathogenesis of NAFLD
[15]. Intracellular FFA accumulation was associated with
an inflammatory response elicited by an increased gene
expression of IL-6, IL-8 and TNF-alpha, and increased
IL-8 protein release. This inflammatory response has
been described as a recruitment stimulus and inductor
o fi n s u l i nr e s i s t a n c e[ 2 5 , 3 0 ] .T h ei n c r e a s ei nt h eg e n e
expression was rather substantial (3 to 5 folds) for all
the 3 cytokines explored at the highest FFA concentra-
tion used (1200 μM) indicating that the inflammatory
reaction of the hepatocyte is rapid (24 h) and consistent.
The behavior of the 3 cytokines is however, different.
While the increment in gene expression for both IL-6
and IL-8 was dose-dependent, this was not true for
TNF-alpha in which only the highest dose of FFA was
a b l ei n c r e a s et h ee x p r e s s i o n .T h ed i f f e r e n c ep a t t e r n
among the 3 cytokines was also confirmed by the
amount of cytokines release into the medium. While the
IL-8 release showed a clear dose-dependency in line
with the gene expression, this was not the case for
TNF-alpha. A different response has been reported pre-
viously in humans and in vitro models, and several
hypothesis were made to explain the differential tem-
poral pattern of RNA expression and protein production
[31].
As mentioned before, while it is known that liver cells
are directly involved in fibrogenesis [2,16], the extent and
the timing of this process is still largely unknown. The
increased expression of TGFb1, CTGF and THBS shows
that the hepatocyte is able to produce effectors for
endothelial and hepatic stellate cells. The up-regulation
of a set of genes able to induce fibrosis has been
described in other chronic liver diseases [2]. In our
model several factors involved in apoptosis regulation,
extracellular matrix production, and hepatic stellate cells
activation were up-regulated. Albeit many responses
were observed in this model, inflammation and induction
of apoptosis seem to be the most significant. Apoptosis is
considered one of the most important activator of hepatic
stellate cells [32]. FFA induce an increased production of
alpha-smooth muscle actin, TGFb1, tissue inhibitor of
metalloproteinase 1, and anti-apoptotic proteins [33].
However some paradoxical effects has been described, as
the reduction in the collagen 1a expression with the
addition of FFA to hepatic stellate cells culture media
[34]. In line with this is the demonstration in our study
that FFA increase the number of early apoptotic cells.
Human NAFLD is associated with oxidative stress, and
the resultant lipid peroxidation may determine the transi-
tion from simple steatosis to NASH [35]. In our in vitro
model, FFA treatment induces an increased content of
intracellular ROS similar to that produced by the expo-
sure of the cells to a known oxidative agent as hydrogen
peroxide. Of notice was the observation that the
increased ROS generation following intracellular FFA
accumulation was almost completed blunted by co-treat-
ing the cells with a known antioxidant agent such as
NAC. These data are in agreement with a recent study
[19] which suggested that not the production of ROS per
se, but rather the insufficient or depleted antioxidant
defenses is one of the mechanisms associated with the
progression of the disease.
One of the main limitation of this study is the use of a
HuH7 cell line derived from a well differentiated liver
carcinoma [35]. Although these cells do show several
characteristics of normal hepatocyte [36], the neoplastic
derivation calls for caveats in exporting the observation
to the much more complex in vivo situation. Despite
the intrinsic limitations of in vitro studies [27], this
novel approach confirm the active participation of the
hepatocytes in the damage observed in NAFLD subjects.
In addition the model may be also relevant as the hepa-
tocyte has autocrine and paracrine effects on the other
resident liver cells [37]. This paracrine relationship is
important not only to understand the fibrosis related
process, but may be useful to identify candidates for
new therapeutic approaches [ 3 5 ] .T h i si sp a r t i c u l a r l y
important in NAFLD where few options are effective.
This manuscript is a proof of concept regarding the
effects of lipotoxicity in hepatocytes, focused on those
factors involved in the fibrogenic stimuli, and attempts
to provide additional support for the NAFLD potential-
ity in developing fibrosis and related complications. It
also highlights the independent role of fatty acids in
NAFLD. Although the advantages and disadvantages of
an in vitro model, the main advantage of such an
approach is the possibility to dissect the different
aspects involved in the pathogenic process in NAFLD,
potentially contributing to the improvement of the cur-
rent diagnostics and therapeutic strategies.
Conclusions
In conclusion this study demonstrates that FFA induce a
wide response on the hepatocyte, ranging from inflam-
mation, increase of oxidative stress, apoptosis and the
production of fibrogenic cytokines. It also shows a pri-
mary role of FFA in the pathogenesis of NAFLD.
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Additional file 1: Figure S1. Increased reactive oxigen species in cells
treated with fatty acids.
Additional file 2: Figure S2. ROS generation on HuH7 cells treated with
1200 μM FFA, mixed with N-acetyl-L-cysteine, or hydrogen peroxide.
Measured by spectrophotometric quantification of H2DCFDA (upper
panel) and flow cytometry (lower panel). *P < 0.05 versus control (0 μM).
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